Skip to main content

Headlines

Jade Biosciences Advances JADE301 Toward Phase 1 Trial In Dermatomyositis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Silexion Doses First Patient In Phase 2/3 SIL204 Trial For Pancreatic Cancer
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Lilly's EBGLYSS Shows Rapid Skin Clearance And Symptom Relief In Phase 3b Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Satellos Completes Enrollment In Phase 2 Forazapadin Trial For DMD
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Connect Biopharma Reports Positive Phase 2 Rademikibart Data In Acute COPD
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Rafael Reports Phase 3 Trappsol Cyclo Data In NPC
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Zealand Publishes New Phase 2 Data For Petrelintide Showing Improved Cardiometabolic Benefits
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Takeda Says Zasocitinib Tops Deucravacitinib With Superior Skin Clearance In Phase 3 Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AbbVie Reports Positive Phase 2 Results For Zumilokibart In Atopic Dermatitis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AbbVIe's Zumilokibart Meets Phase 2 Goal In Atopic Dermatitis Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Takeda's Zasocitinib Shows Superior Skin Clearance In Phase 3 Psoriasis Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Retatrutide Drives Significant Weight Loss And A1C Improvement In Phase 3 Diabetes Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Retatrutide Delivered Significant Weight Loss, A1C Reduction In Phase 3 Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Vanda Reports Positive Phase 3 Results For HETLIOZ In Delayed Sleep-Wake Phase Disorder; Stock Up
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Vanda's HETLIOZ Meets Phase 3 Goal In Delayed Sleep-Wake Phase Disorder; Stock Up
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets